Source comparison
Melanotan-2 Safe Side Effects: Comparison Across Doses
0.1–0.25mg (titration start) 15–20% Minimal. Heart rate +2–4 bpm, no significant BP change 10–15% Visible pigmentation after 10–14 days Lowest adverse event profile; appropriate starting point for all naive subjects; allows receptor adaptation before therapeut
This comparison does not assign a generated winner or score.
- 0.1–0.25mg (titration start)
- 15–20%
- Minimal. Heart rate +2–4 bpm, no significant BP change
- 10–15%
- Visible pigmentation after 10–14 days
- Lowest adverse event profile; appropriate starting point for all naive subjects; allows receptor adaptation before therapeutic dosing
- 0.5mg (standard maintenance)
- 35–45%
- Moderate. Heart rate +6–10 bpm, systolic BP +4–8 mmHg
- 40–50%
- Noticeable tanning within 5–7 days
- Therapeutic window for most research applications; side effects predictable and time-limited; cardiovascular changes return to baseline within 6–8 hours
- 1mg (higher end)
- 60–70%
- Significant. Heart rate +10–15 bpm, systolic BP +8–12 mmHg
- 65–75%
- Rapid tanning within 3–5 days
- Adverse event frequency exceeds 60%; cardiovascular strain warrants continuous monitoring; not recommended without prior tolerance establishment
- >1.5mg (excessive)
- 80–90%
- Severe. Heart rate +15–20 bpm, systolic BP +12–18 mmHg, risk of hypertensive crisis in susceptible individuals
- 85–95%
- Accelerated but not proportionally greater than 1mg
- Risk-benefit ratio unfavorable; side effect severity outweighs marginal tanning acceleration; documented cases of acute adverse cardiovascular events